Ovarian cancer screening
This article was originally published in The Gray Sheet
National Institutes of Health holding consensus conference April 5-7 on ovarian cancer screening, treatment and follow-up. "Because diagnosis at early stages is difficult, major efforts are underway to identify appropriate screening tests for ovarian cancer," a recent NIH release notes. Also, "minimal-access surgical techniques, specifically laparoscopy, may increase in importance for diagnosing and identifying the stages of cancer"
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.